TSHA Taysha Gene Therapies, Inc.: institutional ownership and insider trading
220 funds reported holding $2.15B of Taysha Gene Therapies, Inc. in their latest 13F filings; in Q2 2026 funds net bought $235M, with 39 new positions and 23 funds selling out; over the last 12 months insiders bought $0 and sold $6.66M on the open market; over its last four quarters it reported revenue of $5.49M and net income of −$150M.
TSHA revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0, net income −$46.6M, EPS -0.13
- Quarter ended Mar 31, 2026: revenue $0, net income −$42.4M, EPS -0.12
- Quarter ended Dec 31, 2025: revenue $5.49M, net income −$27.9M, EPS -0.08
- Quarter ended Sep 30, 2025: revenue $0, net income −$32.7M, EPS -0.09
Famous investors holding TSHA
- D. E. Shaw (D. E. Shaw & Co.): $30.0M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $14.5M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $11.7M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.60M, 0.0% of the portfolio
Largest institutional holders of TSHA
- Avoro Capital Advisors LLC — $163M
- RA CAPITAL MANAGEMENT, L.P. — $160M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $155M
- BlackRock, Inc. (BLK) — $141M
- Vestal Point Capital, LP — $132M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $112M
- RTW INVESTMENTS, LP — $92.3M
- FMR LLC — $90.8M
- VANGUARD CAPITAL MANAGEMENT LLC — $85.0M
- STATE STREET CORP (STT, STT-PG) — $77.8M
Recent TSHA insider trades
- Jul 10, 2026: Nagendran Sukumar sold 200,000 shares ($1.25M)
- Apr 10, 2026: Nagendran Sukumar sold 200,000 shares ($892K)
- Feb 4, 2026: Alam Kamran sold 1,655 shares ($7.48K)
- Jan 26, 2026: Nolan Sean P. sold 178,101 shares ($840K)
5%+ owners
- RA Capital Management, L.P.: 9.9% (Schedule 13G/A, filed Aug 14, 2026)
- RTW Investments, LP: 7.0% (Schedule 13G/A, filed May 15, 2026)
- Vestal Point Capital, LP: 6.3% (Schedule 13G/A, filed May 15, 2026)
- Morgan Stanley: 5.1% (Schedule 13G/A, filed Aug 13, 2026)
Who owns the most TSHA stock?
The largest institutional holders of Taysha Gene Therapies, Inc. in the latest 13F filings are Avoro Capital Advisors LLC ($163M), RA CAPITAL MANAGEMENT, L.P. ($160M), GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) ($155M).
Are insiders buying or selling TSHA?
Over the last 12 months insiders bought $0 and sold $6.66M of Taysha Gene Therapies, Inc. stock on the open market (SEC Form 4).
Which famous investors own TSHA?
D. E. Shaw, Izzy Englander, Ken Griffin, Two Sigma.
What was TSHA's revenue last quarter?
Taysha Gene Therapies, Inc. reported revenue of $0 for the quarter ended June 30, 2026, with net income of −$46.6M.
Which ETFs hold TSHA?
7 ETFs and mutual funds hold it among their top 100 positions, including XBI, UISCX, SBIO, PBSIX.